珈凯生物
(920165)
| 流通市值：0.00万 | | | 总市值：0.00万 |
| 流通股本：0.00万 | | | 总股本：0.00万 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 100,224,320.18 | 68,996,515.83 | 54,620,926.54 | 76,898,716.03 |
| 交易性金融资产 | 30,019,424.66 | 50,024,684.93 | 30,000,000 | - |
| 应收票据及应收账款 | 54,324,840.68 | 44,423,543.02 | 54,854,653.61 | 41,216,313.08 |
| 应收账款 | 54,324,840.68 | 44,423,543.02 | 54,854,653.61 | 41,216,313.08 |
| 预付款项 | 2,437,814.54 | 2,621,886.27 | 2,920,121.94 | 1,539,324.98 |
| 其他应收款合计 | 2,479,480.78 | 4,099,095.87 | 2,823,656.45 | 2,265,911.81 |
| 存货 | 21,768,498.94 | 16,982,197.82 | 21,991,280.67 | 22,438,634.88 |
| 其他流动资产 | 6,026,527.22 | 5,040,784.76 | 4,692,737.8 | 2,063,168.11 |
| 流动资产合计 | 217,280,907 | 192,188,708.5 | 171,903,377.01 | 146,422,068.89 |
| 非流动资产: | | | | |
| 固定资产 | 268,527,449.9 | 272,161,807.21 | 276,618,023.55 | 281,115,890.1 |
| 在建工程 | 325,672.56 | 1,861,844.32 | 1,858,125.1 | 1,495,962.17 |
| 使用权资产 | 349,595.84 | 466,127.84 | 582,659.84 | 699,191.84 |
| 无形资产 | 18,865,978.13 | 19,176,971.14 | 19,596,410.18 | 20,019,684.02 |
| 长期待摊费用 | 2,991,907.78 | 2,990,165.04 | 2,530,681.17 | 1,722,374.33 |
| 递延所得税资产 | 2,726,651.88 | 1,639,043.95 | 2,560,063.15 | 2,056,077.82 |
| 其他非流动资产 | 2,180,554.14 | 1,655,250.59 | 1,100,625.37 | 1,199,147.93 |
| 非流动资产合计 | 295,967,810.23 | 299,951,210.09 | 304,846,588.36 | 308,308,328.21 |
| 资产总计 | 513,248,717.23 | 492,139,918.59 | 476,749,965.37 | 454,730,397.1 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 18,572,318.02 | 12,286,326.22 | 19,007,124.67 | 19,192,431.96 |
| 应付账款 | 18,572,318.02 | 12,286,326.22 | 19,007,124.67 | 19,192,431.96 |
| 合同负债 | 713,978.02 | 1,072,216.08 | 992,760.33 | 863,644.71 |
| 应付职工薪酬 | 8,426,018.68 | 15,211,636.25 | 10,248,689.94 | 10,704,987.69 |
| 应交税费 | 6,532,730.65 | 5,862,665.57 | 7,166,752.09 | 3,975,931.55 |
| 其他应付款合计 | 1,346,187.55 | 959,498.22 | 1,004,472.63 | 1,059,454.33 |
| 一年内到期的非流动负债 | 472,204.5 | 623,158.48 | 607,454.56 | 596,695.74 |
| 其他流动负债 | 854,507.23 | 269,861.93 | 735,259.36 | 372,632.61 |
| 流动负债合计 | 36,917,944.65 | 36,285,362.75 | 39,762,513.58 | 36,765,778.59 |
| 非流动负债: | | | | |
| 长期借款 | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 |
| 租赁负债 | - | - | 156,391.31 | 310,882.33 |
| 预计负债 | 921,698.77 | 376,513.28 | 742,959.94 | 476,463.87 |
| 递延收益 | 3,011,314.87 | 3,116,360.75 | 3,431,406.63 | 3,536,452.52 |
| 递延所得税负债 | 304,792.68 | 320,058.08 | 330,831.69 | 345,308.05 |
| 非流动负债合计 | 14,237,806.32 | 13,812,932.11 | 14,661,589.57 | 14,669,106.77 |
| 负债合计 | 51,155,750.97 | 50,098,294.86 | 54,424,103.15 | 51,434,885.36 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 41,033,196 | 41,033,196 | 41,033,196 | 41,033,196 |
| 资本公积 | 243,694,885.52 | 242,946,862.94 | 242,198,840.36 | 241,450,817.78 |
| 盈余公积 | 20,516,598 | 20,516,598 | 15,960,067.34 | 15,960,067.34 |
| 未分配利润 | 156,848,286.74 | 137,544,966.79 | 123,133,758.52 | 104,851,430.62 |
| 归属于母公司股东权益合计 | 462,092,966.26 | 442,041,623.73 | 422,325,862.22 | 403,295,511.74 |
| 股东权益合计 | 462,092,966.26 | 442,041,623.73 | 422,325,862.22 | 403,295,511.74 |
| 负债和股东权益合计 | 513,248,717.23 | 492,139,918.59 | 476,749,965.37 | 454,730,397.1 |
| 公告日期 | 2026-04-21 | 2026-03-20 | 2025-11-10 | 2025-08-26 |
| 审计意见(境内) | | 标准无保留意见 | | 标准无保留意见 |